Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for PONV in Abdominoplasty
NCT03786562Unknown
- Sponsor
- Assiut University
- Start
- Mar 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in postoperative nausea and vomiting (PONV) and pruritus comparing Placebo group with Nalbuphine group (2 arms). Primary endpoint: Postoperative Nausea and Vomiting at 24 hours. Status: unknown.
02
Drugs
nalbuphine
03
Conditions
postoperative nausea and vomiting (PONV)pruritus
Beyond the preview
Go deeper on NCT03786562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03786562.